CERSCerus Corporation

$358M

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$52M+16.3% YoY

Gross Profit

$29M55.2% margin

Operating Income

-$3M-6.5% margin

Net Income

-$6M-10.9% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

+21.3%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$213M

Total Liabilities

$157M

Stockholders' Equity

$55M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52M	$45M	+16.3%
Gross Profit	$29M	$25M	+17.5%
Operating Income	-$3M	-$4M	+10.8%
Net Income	-$6M	-$6M	+1.2%

Revenue Segments

Product

$52M87%

Government Contract

$8M13%

Geographic Segments

North America

$35M67%

Europe Middle East And Africa

$17M32%

Other

$547,0001%

CERS Q2 2025 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena